Biggest News Aggregation in the World
📰 Thyroid Disorders News

Page 2 - Thyroid Disorders News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Thyroid Disorders. Real-time updates on events, politics, business and more.

Merck Announces Phase 3 Trial Initiations for Four Investigational Candidates From its Promising Hematology and Oncology Pipeline

Global Phase 3 studies started for bomedemstat , nemtabrutinib , MK-2870 and MK-5684 Comprehensive clinical development programs being initiated for each investigational candidate Demonstrates...
United States Drug Administration Exchange Commission Merck Co Inc American Society For Hematology Merck Research Laboratories

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adults with Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy

Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial ...
United States Gregory Lubiniecki Merck Research Laboratories European Union European Organisation For Research Merck Co Inc

Merck Announces Phase 3 KEYNOTE-A18 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer

KEYTRUDA® (pembrolizumab) plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
United States Domenica Lorusso Gursel Aktan European Network For Gynaecological Oncology Trial Foundation Inc Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science